4.6 Article

Shape Effects of Peptide Amphiphile Micelles for Targeting Monocytes

Journal

MOLECULES
Volume 23, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/molecules23112786

Keywords

monocytes; peptide amphiphile micelles; monocyte targeting; nanoparticle shape

Funding

  1. Genomics and Geobiology Undergraduate Research Experience (GGURE) program at University of Southern California (USC)
  2. Gabilan Assistant Professorship
  3. L.K. Whittier Foundation
  4. National Heart, Lung, and Blood Institute (NHLBI) [R00HL124279]
  5. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL124279] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Peptide amphiphile micelles (PAMs) are a nanoparticle platform that have gained popularity for their targeting versatility in a wide range of disease models. An important aspect of micelle design is considering the type of hydrophobic moiety used to synthesize the PAM, which can act as a contributing factor regarding their morphology and targeting capabilities. To delineate and compare the characteristics of spherical and cylindrical micelles, we incorporated the monocyte-targeting chemokine, monocyte chemoattractant protein-1 (MCP-1), into our micelles (MCP-1 PAMs). We report that both shapes of nanoparticles were biocompatible with monocytes and enhanced the secondary structure of the MCP-1 peptide, thereby improving the ability of the micelles to mimic the native MCP-1 protein structure. As a result, both shapes of MCP-1 PAMs effectively targeted monocytes in an in vitro binding assay with murine monocytes. Interestingly, cylindrical PAMs showed a greater ability to attract monocytes compared to spherical PAMs in a chemotaxis assay. However, the surface area, the multivalent display of peptides, and the zeta potential of PAMs may also influence their biomimetic properties. Herein, we introduce variations in the methods of PAM synthesis and discuss the differences in PAM characteristics that can impact the recruitment of monocytes, a process associated with disease and cancer progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell & Tissue Engineering

Transdermal Delivery of Kidney-Targeting Nanoparticles Using Dissolvable Microneedles

Nirmalya Tripathy, Jonathan Wang, Madelynn Tung, Claire Conway, Eun Ji Chung

CELLULAR AND MOLECULAR BIOENGINEERING (2020)

Article Biotechnology & Applied Microbiology

The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles

Yi Huang, Kairui Jiang, Xuting Zhang, Eun Ji Chung

BIOENGINEERING & TRANSLATIONAL MEDICINE (2020)

Review Medicine, Research & Experimental

Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes

Noah Trac, Eun Ji Chung

Summary: Lymph nodes are crucial sites for cancer metastasis and immune activity, making them important clinical targets. Intravenous drug delivery, while advantageous for lymph node targeting, faces challenges such as rapid clearance and physical barriers, driving research into nanoparticle-based drug delivery systems to improve efficiency in lymph node drug delivery.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

Article Engineering, Biomedical

miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype

Deborah D. Chin, Christopher Poon, Jonathan Wang, Johan Joo, Victor Ong, Zhangjingyi Jiang, Kayley Cheng, Anastasia Plotkin, Gregory A. Magee, Eun Ji Chung

Summary: The delivery of miR-145 micelles to VSMCs shows promise in mitigating atherosclerosis progression by altering cell phenotypes and reducing plaque growth. In mouse experiments, miR-145 micelles significantly inhibited the advancement of atherosclerosis.

BIOMATERIALS (2021)

Review Biochemistry & Molecular Biology

Strategies to deliver RNA by nanoparticles for therapeutic potential

Alysia Cox, Siyoung A. Lim, Eun Ji Chung

Summary: The use of various types of RNA molecules for prevention and therapy of pathologies has shown great potential. However, limitations such as short in vivo half-life, lack of targeted delivery, and safety issues have hindered the therapeutic efficacy. Nanoparticle-mediated delivery has been successful in overcoming these limitations, with multiple formulations already in clinical trials and approved by FDA. This review summarizes the methods of modifying nanoparticles for optimal therapeutic effects in RNA delivery.

MOLECULAR ASPECTS OF MEDICINE (2022)

Article Medicine, Research & Experimental

Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis

Kuang-Yuh Chyu, Xiaoning Zhao, Jianchang Zhou, Paul C. Dimayuga, Nicole Wm Lio, Bojan Cercek, Noah T. Trac, Eun Ji Chung, Prediman K. Shah

Summary: This study explored the possibility of delivering apolipoprotein B-100 (ApoB-100) peptide P210 as an antigen using nanoparticles to reduce atherosclerosis. The researchers characterized the T cell responses to P210 in patients with atherosclerotic cardiovascular disease and demonstrated the potential mechanisms of action of P210-PAM in a mouse model. The study also showed the clinical relevance of P210-PAM immunization in reducing atherosclerosis.

JCI INSIGHT (2022)

Article Cell & Tissue Engineering

Combining Metformin and Drug-Loaded Kidney-Targeting Micelles for Polycystic Kidney Disease

Kairui Jiang, Yi Huang, Eun Ji Chung

Summary: This study demonstrates for the first time the drug synergy using drug-loaded nanoparticles and free MET for the treatment of ADPKD. The combination of MET with all drug-loaded nanoparticles significantly enhanced the efficacy in inhibiting cell proliferation and cyst growth. Synergistic effects were found for MET and nanoparticles loaded with either salsalate or rapamycin.

CELLULAR AND MOLECULAR BIOENGINEERING (2023)

Review Biotechnology & Applied Microbiology

Extracellular Vesicles as Regulators of the Extracellular Matrix

Neil J. J. Patel, Anisa Ashraf, Eun Ji Chung

Summary: Extracellular vesicles (EVs) are small membrane-bound vesicles that are secreted by all cell types into the extracellular space. They transfer nucleic acids, proteins, and lipids to facilitate cell-to-cell communication. EVs interact with the extracellular matrix (ECM) and play a role in both its organization and degradation. Furthermore, they influence recipient cells to remodel the ECM in pathological and therapeutic contexts.

BIOENGINEERING-BASEL (2023)

Article Chemistry, Multidisciplinary

Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions

Noah Trac, Anisa Ashraf, Joshua Giblin, Supriya Prakash, Samir Mitragotri, Eun Ji Chung

Summary: Nanoparticles, as drug delivery carriers, have been effective in treating various diseases, including cancer, since the 1990s. Recently, their potential to combat global diseases like COVID-19 has been demonstrated. However, there is limited research on nanomedicine for chronic kidney diseases (CKDs) which affect a significant number of individuals worldwide. This article provides an overview of the clinical status of genetic kidney diseases, nanoparticle design for kidney targeting, and emerging technological strategies for treating genetic kidney diseases.

ACS NANO (2023)

Article Biochemical Research Methods

In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease

Alysia Cox, Madelynn Tung, Hui Li, Kenneth R. Hallows, Eun Ji Chung

Summary: Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic kidney disease characterized by renal cyst formation. Inhibition of the mTOR pathway has been proposed as a potential treatment approach. This study focused on encapsulating mTOR inhibitors in drug delivery carriers that target the kidneys. The results show promising efficacy of the encapsulated drugs in inhibiting cell proliferation in vitro. Encapsulation in peptide amphiphile micelle (PAM) nanoparticles could be a potential strategy for delivering mTOR inhibitors to treat ADPKD.

SLAS TECHNOLOGY (2023)

Article Chemistry, Multidisciplinary

Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions

Noah Trac, Anisa Ashraf, Joshua Giblin, Supriya Prakash, Samir Mitragotri, Eun Ji Chung

Summary: Nanoparticles as drug delivery carriers have shown great potential in treating various diseases, including cancer, as well as in the fight against global pandemics like COVID-19. However, there is still limited research on nanomedicine for chronic kidney diseases, especially genetic kidney diseases. This perspective provides an overview of the clinical status of genetic kidney diseases, kidney physiology, nanoparticle design, and emerging technological strategies that can be applied to address this challenge.

ACS NANO (2023)

Article Pharmacology & Pharmacy

Collagenase-Cleavable Peptide Amphiphile Micelles as a Novel Theranostic Strategy in Atherosclerosis

Deborah D. Chin, Christopher Poon, Noah Trac, Jonathan Wang, Johan Joo, Zhangjingyi Jiang, Naomi Sulit Sta Maria, Russell E. Jacobs, Eun Ji Chung, Jackson Cook

ADVANCED THERAPEUTICS (2020)

Article Materials Science, Biomaterials

Hydroxyapatite-binding micelles for the detection of vascular calcification in atherosclerosis

Deborah D. Chin, Jonathan Wang, Margot Mel de Fontenay, Anastasia Plotkin, Gregory A. Magee, Eun Ji Chung

JOURNAL OF MATERIALS CHEMISTRY B (2019)

Article Engineering, Biomedical

Calcium-Binding Nanoparticles for Vascular Disease

Deborah D. Chin, Sampreeti Chowdhuri, Eun Ji Chung

REGENERATIVE ENGINEERING AND TRANSLATIONAL MEDICINE (2019)

No Data Available